Literature DB >> 10102636

A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3.

S Dennler1, S Huet, J M Gauthier.   

Abstract

Smad proteins are essential components of the signalling cascade initiated by members of the Transforming Growth Factor-beta family. TGFbeta binding to heteromeric complexes of transmembrane Ser/Thr kinases induces Smad2 and Smad3 phosphorylation on their C terminus residues. This phosphorylation leads to oligomerization with Smad4, a common mediator of TGF-beta, activin and BMP signalling. The Smad complexes then translocate to the nucleus where they play transcription regulator roles. Even if they share 92% identity, the two TGFbeta/ restricted Smad2 and Smad3 are not functionally equivalent. As we have previously shown, Smad3 acts as a transcription factor by binding to a TGFbeta-responsive sequence termed CAGA box whereas Smad2 does not. Smad2 differs from Smad3 mainly in the N-terminal MH1 domain where it contains two additional stretches of amino acids that are lacking in Smad3. Here, we show that one of these domains corresponding to exon 3 is responsible for the absence of Smad2 transcriptional activity in CAGA box-containing promoters. Furthermore, in vitro studies indicate that this domain prevents Smad2 from binding to this DNA sequence. This suggests that Smad2 and Smad3 may have different subsets of target genes participating thus in distinct responses among TGFbeta pleiotropic effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10102636     DOI: 10.1038/sj.onc.1202729

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  48 in total

1.  Structural basis for the functional difference between Smad2 and Smad3 in FAST-2 (forkhead activin signal transducer-2)-mediated transcription.

Authors:  R P Nagarajan; Y Chen
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

2.  Alteration of transforming growth factor-beta1 response involves down-regulation of Smad3 signaling in myofibroblasts from skin fibrosis.

Authors:  P Reisdorf; D A Lawrence; V Sivan; E Klising; M T Martin
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Mutant FOXL2C134W Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell Tumors.

Authors:  Stine E Weis-Banke; Mads Lerdrup; Daniela Kleine-Kohlbrecher; Faizaan Mohammad; Simone Sidoli; Ole N Jensen; Toshihiko Yanase; Tomoko Nakamura; Akira Iwase; Anthe Stylianou; Nadeem R Abu-Rustum; Carol Aghajanian; Robert Soslow; Arnaud Da Cruz Paula; Richard P Koche; Britta Weigelt; Jesper Christensen; Kristian Helin; Paul A C Cloos
Journal:  Cancer Res       Date:  2020-07-08       Impact factor: 12.701

Review 4.  SMAD regulatory networks construct a balanced immune system.

Authors:  Nidhi Malhotra; Joonsoo Kang
Journal:  Immunology       Date:  2013-05       Impact factor: 7.397

5.  TGF-β1/Smad2/3/Foxp3 signaling is required for chronic stress-induced immune suppression.

Authors:  Haiju Zhang; Yi Caudle; Clay Wheeler; Yu Zhou; Charles Stuart; Baozhen Yao; Deling Yin
Journal:  J Neuroimmunol       Date:  2017-11-08       Impact factor: 3.478

6.  Interaction between the transforming growth factor-beta type II receptor/Smad pathway and beta-catenin during transforming growth factor-beta1-mediated adherens junction disassembly.

Authors:  Ya Chung Tian; Aled Owain Phillips
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

7.  TGFβ splicing and canonical pathway activation in high-grade serous carcinoma.

Authors:  Neriya Gutgold; Ben Davidson; Liora Jacobs Catane; Arild Holth; Ellen Hellesylt; Claes G Tropé; Anne Dørum; Reuven Reich
Journal:  Virchows Arch       Date:  2017-04-21       Impact factor: 4.064

8.  Hierarchical model of gene regulation by transforming growth factor beta.

Authors:  Yaw-Ching Yang; Ester Piek; Jiri Zavadil; Dan Liang; Donglu Xie; Joerg Heyer; Paul Pavlidis; Raju Kucherlapati; Anita B Roberts; Erwin P Böttinger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

9.  Transforming growth factor beta promotes complexes between Smad proteins and the CCCTC-binding factor on the H19 imprinting control region chromatin.

Authors:  Rosita Bergström; Katia Savary; Anita Morén; Sylvain Guibert; Carl-Henrik Heldin; Rolf Ohlsson; Aristidis Moustakas
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

10.  Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins.

Authors:  Z A Quinn; C C Yang; J L Wrana; J C McDermott
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.